Evaluating reporter genes of different luciferases for optimized in vivo bioluminescence imaging of transplanted neural stem cells in the brain. (November 2013)
- Record Type:
- Journal Article
- Title:
- Evaluating reporter genes of different luciferases for optimized in vivo bioluminescence imaging of transplanted neural stem cells in the brain. (November 2013)
- Main Title:
- Evaluating reporter genes of different luciferases for optimized in vivo bioluminescence imaging of transplanted neural stem cells in the brain
- Authors:
- Mezzanotte, Laura
Aswendt, Markus
Tennstaedt, Annette
Hoeben, Rob
Hoehn, Mathias
Löwik, Clemens
Aime, Silvio
Muller, Robert N. - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Bioluminescence imaging (BLI) has become the method of choice for optical tracking of cells in small laboratory animals. However, the use of luciferases from different species, depending on different substrates and emitting at distinct wavelengths, has not been optimized for sensitive neuroimaging. In order to identify the most suitable luciferase, this quantitative study compared the luciferases Luc2, CBG99, PpyRE9 and hRluc. Human embryonic kidney (HEK‐293) cells and mouse neural stem cells were transduced by lentiviral vector‐mediated transfer to express one of the four luciferases, together with copGFP. A T2A peptide linker promoted stoichiometric expression between both imaging reporters and the comparison of cell populations upon flow cytometry. Cell dilution series were used to determine highest BLI sensitivity <italic>in vitro</italic> for Luc2. However, Coelenterazine h‐dependent hRluc signals clearly exceeded <sc>d</sc>‐luciferin‐dependent BLI <italic>in vitro</italic>. For the quantitative <italic>in vivo</italic> analysis, cells were transplanted into mouse brain and BLI was performed including the recording of emission kinetics and spectral characteristics. Differences in light kinetics were observed for <sc>d</sc>‐luciferin vs Coelenterazine h. The emission spectra of Luc2 and PpyRE9 remained almost unchanged, while the emission spectrum of CBG99 became biphasic. Most<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Bioluminescence imaging (BLI) has become the method of choice for optical tracking of cells in small laboratory animals. However, the use of luciferases from different species, depending on different substrates and emitting at distinct wavelengths, has not been optimized for sensitive neuroimaging. In order to identify the most suitable luciferase, this quantitative study compared the luciferases Luc2, CBG99, PpyRE9 and hRluc. Human embryonic kidney (HEK‐293) cells and mouse neural stem cells were transduced by lentiviral vector‐mediated transfer to express one of the four luciferases, together with copGFP. A T2A peptide linker promoted stoichiometric expression between both imaging reporters and the comparison of cell populations upon flow cytometry. Cell dilution series were used to determine highest BLI sensitivity <italic>in vitro</italic> for Luc2. However, Coelenterazine h‐dependent hRluc signals clearly exceeded <sc>d</sc>‐luciferin‐dependent BLI <italic>in vitro</italic>. For the quantitative <italic>in vivo</italic> analysis, cells were transplanted into mouse brain and BLI was performed including the recording of emission kinetics and spectral characteristics. Differences in light kinetics were observed for <sc>d</sc>‐luciferin vs Coelenterazine h. The emission spectra of Luc2 and PpyRE9 remained almost unchanged, while the emission spectrum of CBG99 became biphasic. Most importantly, photon emission decreased in the order of Luc2, CBG99, PpyRE9 to hRluc. The feasibility of combining different luciferases for dual color and dual substrate neuroimaging was tested and discussed. This investigation provides the first complete quantitative comparison of different luciferases expressed by neural stem cells. It results in a clear recommendation of Luc2 as the best luciferase selection for <italic>in vivo</italic> neuroimaging. Copyright © 2013 John Wiley &amp; Sons, Ltd.</p> </abstract> … (more)
- Is Part Of:
- Contrast media & molecular imaging. Volume 8:Number 6(2013:Nov./Dec.)
- Journal:
- Contrast media & molecular imaging
- Issue:
- Volume 8:Number 6(2013:Nov./Dec.)
- Issue Display:
- Volume 8, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 8
- Issue:
- 6
- Issue Sort Value:
- 2013-0008-0006-0000
- Page Start:
- 505
- Page End:
- 513
- Publication Date:
- 2013-11
- Subjects:
- Diagnostic imaging -- Periodicals
Magnetic resonance imaging -- Periodicals
Contrast media (Diagnostic imaging) -- Periodicals
Contrast Media -- Periodicals
Diagnostic Imaging -- Periodicals
Substances de contraste -- Périodiques
Diagnostics moléculaires -- Périodiques
Imagerie médicale
Substance de contraste
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.0754 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/15554317 ↗
https://www.hindawi.com/journals/cmmi/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmmi.1549 ↗
- Languages:
- English
- ISSNs:
- 1555-4309
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3426.351450
British Library HMNTS - ELD Digital store - Ingest File:
- 4204.xml